XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Cash flow provided by (used in) operating activities:    
Net income $ 224,365 $ 132,546
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 33,181 30,285
Stock-based compensation 16,279 16,802
Income (Loss) from unconsolidated entities (11,677) (7,870)
Distributions of earnings from unconsolidated entities 11,464 16,427
Deferred tax (benefit) provision 3,222 2,309
Inventory impairments and write-offs 2,847 15,245
Gain (Loss) on Disposition of Assets (38,706) (12,970)
Other 1,882 127
Gain (Loss) on Extinguishment of Debt 35,211 0
Changes in operating assets and liabilities    
Inventory (528,048) (247,104)
Origination of mortgage loans (906,251) (745,847)
Sale of mortgage loans 929,763 823,354
Receivables, prepaid expenses and other assets 77,624 (173,249)
Income Taxes Receivable (17,276) (11,815)
Customer deposits, net 132,840 33,271
Accounts payable and accrued expenses 60,449 (62,647)
Income taxes payable 98 0
Net Cash Provided by (Used in) Operating Activities, Continuing Operations 27,267 (191,136)
Cash flow (used in) provided by investing activities:    
Purchase of property and equipment - net (29,606) (50,757)
Investments in and advances to unconsolidated entities (153,828) (10,263)
Return of investments in unconsolidated entities 144,047 34,884
Proceeds from sales of golf club property and an office building 80,418 15,617
Acquisition of a business 0 (60,349)
Other investing changes 579 1,159
Net Cash (Used in) Provided By Investing Activities, Continuing Operations 41,610 (69,709)
Cash flow used in financing activities:    
Proceeds from loans payable 1,335,309 2,732,493
Repayments of loans payable (1,548,152) (2,354,113)
Redemption of senior notes (294,168) 0
(Payments) proceeds from stock-based benefit plans 7,569 5,305
Purchase of treasury stock (179,648) (633,553)
Dividends paid (35,272) (28,783)
Proceeds from (Payments to) Noncontrolling Interests (4,718) (936)
Net Cash Used in Financing Activities, Continuing Operations (719,080) (279,587)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (650,203) (540,432)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 1,396,604 1,319,643
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period $ 746,401 $ 779,211